PE
Patrick G Enright
Director10% Owner

Patrick G Enright insider trades: Veradermics (MANE) stock buys and sales

Director, Veradermics Last trade Feb 5, 2026 190 Form 4 filings
$664K
Sold, last 12 months
3 sales
$18.5M
Bought, last 12 months
2 buys
158
Open-market trades
since 2005
25
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Patrick reports to the SEC

and 19 more companies

Open-market buys and sales

158 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 5, 2026MANE↑ Buy$18.3M
Feb 4, 2026RPID↓ Sell$190K
Feb 3, 2026RPID↓ Sell$442K
Jan 23, 2026RPID↓ Sell$31K
Dec 11, 2025VERA↑ Buy$250K
Oct 9, 2025ZBIO↑ Buy$2.0M
Oct 9, 2025ZBIO↑ Buy$250K
Jun 24, 2025VERA↑ Buy$5.3M
Sep 27, 2024BIOA↑ Buy$7.2M
Sep 16, 2024ZBIO↑ Buy$7.5M
Nov 7, 2023LXEO↑ Buy$5.0M
Aug 14, 2023JAZZ↓ Sell$171K
Feb 6, 2023VERA↑ Buy$12.0M
Nov 22, 2022JAZZ↓ Sell$744K
Nov 22, 2022JAZZ↓ Sell$306K
Aug 8, 2022JAZZ↓ Sell$166K
Apr 19, 2022INZY↑ Buy$5.0M
Feb 10, 2022VERA↑ Buy$5.0M
Feb 2, 2022SRRA↑ Buy$4.7M
Jul 19, 2021RPID↑ Buy$3.0M
May 18, 2021VERA↑ Buy$10.0M
May 11, 2021TALS↑ Buy$4.0M
Nov 12, 2020JAZZ↓ Sell$1.5M
Oct 20, 2020EAR↑ Buy$4.2M
Aug 28, 2020MTEM↓ Sell$38K
Jul 28, 2020INZY↑ Buy$10.0M
Jul 10, 2020ETNB↑ Buy$3.0M
Mar 18, 2020AIMT↑ Buy$280K
Mar 17, 2020AIMT↑ Buy$1.1M
Jan 10, 2020APTX↑ Buy$500K
Jan 10, 2020APTX↑ Buy$285K
Nov 25, 2019MTEM↑ Buy$7.5M
Nov 11, 2019ETNB↑ Buy$9.2M
Aug 9, 2019JAZZ↓ Sell$98K
Nov 2, 2018AXNX↑ Buy$8.0M
Sep 21, 2018MTEM↑ Buy$2.0M
Sep 6, 2018JAZZ↓ Sell$1.7M
Aug 10, 2018JAZZ↓ Sell$239K
Jul 2, 2018TCDA↑ Buy$2.5M
Jun 25, 2018APTX↑ Buy$2.4M
Feb 22, 2018AIMT↑ Buy$499K
Dec 11, 2017JAZZ↓ Sell$1.3M
Dec 8, 2017COLL↓ Sell$17.0M
Dec 8, 2017COLL↓ Sell$341K
Nov 17, 2017JAZZ↓ Sell$47K
Aug 25, 2017JAZZ↓ Sell$52K
Aug 11, 2017JAZZ↓ Sell$94K
Jul 25, 2017KALA↑ Buy$3.2M
Mar 16, 2017CORT↓ Sell$2.6M
Mar 16, 2017CORT↓ Sell$53K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other MANE insiders

Open-market trades in the last 12 months

About Patrick G Enright's insider trades

Patrick G Enright is a director at Veradermics (MANE). Since Oct 28, 2005, Patrick has reported 45 open-market purchases worth $179.4M and 113 sales worth $384.0M on SEC Form 4. In the last 12 months: 2 buys ($18.5M) and 3 sales ($664K).

10 sales (3% of the value sold) were made under a Rule 10b5-1 trading plan, which is set up months in advance and runs on a schedule, so they say little about how the insider sees the stock today.

Their filings also include grants and awards (72 filings), other transactions (20 filings), conversions (19 filings), option exercises (11 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MANE insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.